The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.
about
Commercial enzyme-linked immunosorbent assay versuspolymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysisHigh throughput selection of effective serodiagnostics for Trypanosoma cruzi infectionChagas diseaseSustainable vector control and management of Chagas disease in the Gran Chaco, Argentina.The challenges of Chagas Disease-- grim outlook or glimmer of hope.Prevalence of transfusion-transmitted Chagas Disease among multitransfused patients in Brazil.Chagas cardiomyopathy in the context of the chronic disease transition.Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina.ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.A field trial of alternative targeted screening strategies for Chagas disease in Arequipa, Peru.Eliminating Chagas disease: challenges and a roadmap.Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.Sensitivity and specificity of an operon immunochromatographic test in serum and whole-blood samples for the diagnosis of Trypanosoma cruzi infection in Spain, an area of nonendemicity.Performance of six diagnostic tests to screen for Chagas disease in blood banks andprevalence of Trypanosoma cruzi infection among donors with inconclusive serologyscreening based on the analysis of epidemiological variablesKinetoplastids: related protozoan pathogens, different diseases.Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine.Problems and perspectives for Chagas disease control: in search of a realistic analysis.Use of Individual-level Covariates to Improve Latent Class Analysis of Trypanosoma Cruzi Diagnostic Tests.A population-based study of the association between Trypanosoma cruzi infection and cognitive impairment in old age (the Bambuí Study).Transplantation for Chagas' disease: an overview of immunosuppression and reactivation in the last two decades.Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.Elimination of Chagas disease transmission: perspectives.Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City.Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening.Viability of red cells prepared with S-303 pathogen inactivation treatment.Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening.Does my patient have chronic Chagas disease? Development and temporal validation of a diagnostic risk score.Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice
P2860
Q26774182-2DA5BACB-2FAF-4EAD-837D-0D670C2B978EQ28473737-DD9D28D2-6BDC-4210-8032-A161FEFF0109Q28755203-2F17ACC2-D62C-4D4D-8CDB-0C505ECDC1CBQ30398205-4AF174BA-09BD-4594-8259-2CAF59ADA798Q33312506-3B1D91C9-FC60-453E-88C9-FECCC4AB5BDBQ33315035-075FC1CF-DF7C-45E3-B7E6-6A2AC8CD70DFQ33587293-8993EFB6-191F-428A-93C7-D9941E10BDAEQ33738243-18E5EC3A-299F-4265-A7F9-F5553AC82ADEQ33756086-0532257B-68F8-40A2-B278-4C5D6E9F2007Q34131239-AC750FD0-053A-49AF-969C-A41220490C5AQ34903450-FAAC1FB3-283C-4588-B1D1-7AFADFFB5F7DQ35965823-FFC46E12-C382-474F-AE56-0C32A66573B3Q36191627-024BB24D-D73C-4CA0-AA54-D4ACF765A187Q36286046-406458D5-889E-4E79-A733-2CE708936BECQ36513308-2FDF051E-2A61-476D-B780-68A9C81CFD6FQ36901969-84487F9F-70D6-46FF-8CA2-E99B8AEAD5B6Q37188565-9EE0F806-B7D1-4794-95C2-4569AB581212Q37204535-7FC7E5FD-A1BB-4392-BC45-19129CD6D33BQ37466869-382382B0-4294-4E3F-957F-8B4C6C530704Q37678605-5E9D59C3-C172-4876-957B-40E68C503C96Q39920545-2CE795EF-A987-4C18-B03E-7951AF861062Q39945109-51D855CC-8A82-476E-B676-47BD46AAE604Q42253066-FDA8D47C-E087-488D-ABD9-0AA7A30319F3Q46859893-FED6CA4C-9906-4DD6-84DE-191B6B6E267BQ50720127-B0469B77-ADD2-49D5-AD2C-B9CF2E273E4FQ53588078-D2B67AD4-4EFC-4734-8718-0DA5551973AFQ53729331-0DA2B488-E268-43DE-9B16-C81436D9A8D3Q58850331-8ED328E4-C105-48AC-9B4C-6D0CD4DC8998
P2860
The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The validity of serologic test ...... gies in a hyperendemic region.
@en
The validity of serologic test ...... gies in a hyperendemic region.
@nl
type
label
The validity of serologic test ...... gies in a hyperendemic region.
@en
The validity of serologic test ...... gies in a hyperendemic region.
@nl
prefLabel
The validity of serologic test ...... gies in a hyperendemic region.
@en
The validity of serologic test ...... gies in a hyperendemic region.
@nl
P2093
P1433
P1476
The validity of serologic test ...... gies in a hyperendemic region.
@en
P2093
Freddy López
Marianne Pirard
Naomi Iihoshi
Paulino Basanta
P304
P356
10.1111/J.0041-1132.2005.04214.X
P577
2005-04-01T00:00:00Z